ClearFlow | Improve Cardiac Surgery Outcomes

𝗗𝗿. 𝗚𝗶𝗹𝗹𝗶𝗻𝗼𝘃 and 𝗔𝗹𝘆𝘀𝗼𝗻 𝗠𝗲𝗵𝗿𝗶𝗻𝗴𝗲𝗿, RN discuss how PleuraFlow helps enable chest tube patency after cardiac surgery. Watch the full webinar here: https://lnkd.in/eWw-nd5J

𝗗𝗿. 𝗠𝗮𝗿𝗰 𝗚𝗶𝗹𝗹𝗶𝗻𝗼𝘃 and 𝗗𝗿. 𝗠𝗮𝗿𝗰 𝗚𝗲𝗿𝗱𝗶𝘀𝗰𝗵 discuss their utilization of PleuraFlow Active Clearance Technology to help maintain chest tube patency after cardiac surgery. Systematic vs Selective Usage. Watch the full webinar here: https://lnkd.in/eWw-nd5J

𝗗𝗿. 𝗠𝗮𝗿𝗰 𝗚𝗲𝗿𝗱𝗶𝘀𝗰𝗵 discusses the process of trialing new technologies and the necessary coordination of all included departments as well as Hospital Administration. Watch the full webinar here: https://lnkd.in/eWw-nd5J

Hear from the experts, 𝗗𝗿. 𝗠𝗮𝗿𝗰 𝗚𝗶𝗹𝗹𝗶𝗻𝗼𝘃 and 𝗗𝗿. 𝗠𝗮𝗿𝗰 𝗚𝗲𝗿𝗱𝗶𝘀𝗰𝗵 regarding their utilization of PleuraFlow's Active Clearance Technology to help maintain chest tube patency and effective drainage following cardiac surgery. Watch the full webinar here: https://lnkd.in/eWw-nd5J

Proactively maintain chest tube patency after cardiac surgery using the PleuraFlow Active Clearance System. Avoid complications due to retained blood. Watch the full webinar here: https://lnkd.in/eWw-nd5J

PleuraFlow's Active Clearance System allows the ICU Nursing Staff to proactively maintain chest tube patency in patients recovering from cardiac surgery. Watch the full webinar here: https://lnkd.in/eWw-nd5J

Patients who underwent active chest tube clearance: ⬇️ Re-exploration ⬇️ Pneumonia ⬇️ POAF Clinical findings support the use of ATC. After heart surgery, the chest tube removes lost mediastinal blood. Clogging of the chest tube may induce inadequate evacuation of fluids surrounding the lungs and heart, leading to deadly consequences. This meta-analysis compared the effectiveness of active chest tube clearance (ATC) with conventional chest tube (CT) in lowering the incidence of retained blood complications after heart surgery. We conducted a systematic search of the available databases to identify cohort studies or clinical trials that met our inclusion criteria. Studies that compared active tube clearance and conventional tube in cardiac surgery were included. The fixed or random-effects model was used to determine the pooled effect estimates upon the heterogeneity of collected data. This review included 7003 people from five cohort studies and three clinical trials. This meta-analysis provides evidence on the positive effect of active maintenance of chest tube patency during the first hours of cardiac surgery, which resulted in reducing the incidence of complications. More on this systematic review and meta-analysis can be found here: https://lnkd.in/gJUvd5gM AUTHORS & AFFILIATIONS: Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt Mohammed Tarek Hasan, Abdulrahman Ibrahim Hagrass, Mohamed Nabil Elkhrashy, Mohamed Hamouda, Anas Zakarya Nourelden & Ahmed Bostamy Elsnhory International Medical Research Association (IMedRA), Cairo, Egypt Mohammed Tarek Hasan, Abdulrahman Ibrahim Hagrass, Mohamed Nabil Elkhrashy, Mohamed Hamouda, Noura Mohamed shada, Sarah M. Hashem, Mohammed Al-kafarna, Hossam Waleed Almadhoon, Khaled Mohamed Ragab, Anas Zakarya Nourelden & Ahmed Bostamy Elsnhory Gamal Abdel Nasser Axis, The 3rd Settlement, New Cairo, Egypt Abdulrahman Ibrahim Hagrass Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt Noura Mohamed shada & Sarah M. Hashem Faculty of Pharmacy, Al-Azhar University, Gaza, Palestine Mohammed Al-kafarna Faculty of Dentistry, Al-Azhar University, Gaza, Palestine Hossam Waleed Almadhoon Faculty of Medicine, Minia University, Minia, Egypt Khaled Mohamed Ragab CONTRIBUTIONS: Conception and design of the work by Khaled Mohamed Ragab and Ahmed Bostamy Elsnhory. Selection process and data collection by Mohammed Tarek Hasan, Mohamed Nabil Elkhrashy, Mohamed Hamouda, Noura Mohamed shada, and Sarah M. Hashem. Data analysis and interpretation by Abdulrahman Ibrahim Hagrass and Khaled Mohamed Ragab. Drafting the article by Mohammed Al-kafarna and Hossam Waleed Madhoon. Critical revision and editing of the article by Abdulrahman Ibrahim Hagrass, Ahmed Bostamy Elsnhory, and Anas Zakarya Nourelden. CORRESPONDING AUTHOR: Correspondence to Abdulrahman Ibrahim Hagrass.

PleuraFlow reduced overall LOS (Length of Stay) by 1 full day, which translates into significant cost savings. Watch the full webinar here: https://lnkd.in/eWw-nd5J

The utilization of PleuraFlow enabled a significant reduction in the need for Transfusions. Watch the full webinar here: https://lnkd.in/eWw-nd5J

Postoperative Bleeding was significantly decreased across the board. PleuraFlow enables more effective drainage and therefore can lead to less bleeding overall. Watch the full webinar here: https://lnkd.in/eWw-nd5J